HealthTürkiye Official institution
Ömer Dinçer elected to vacant board seat at Gen İlaç
Gen İlaç ve Sağlık Ürünleri Sanayi ve Ticaret A.Ş. selected Ömer Dinçer to the board of directors to replace Ali Göl, who resigned. The election was made under Article 363 of the Turkish Commercial Code, and Dinçer will serve until 27.03.2028, completing his predecessor's remaining term. The appointment will be submitted to shareholders for approval at the first Ordinary General Assembly.
What does it mean?
A board member who left has been replaced by a new member; this appointment will depend on shareholder approval at the company's next Ordinary General Assembly meeting.
What changes?
Previously Ali Göl was a board member; now Ömer Dinçer is a member, to complete the remaining term of his predecessor.